Several studies have demonstrated the activation of the IRE1α-XBP1 pathway in AD, e.g., p-IRE1α and XBP1s are elevated in different regions of the human brain of patients affected with AD (Hoozemans et al., 2009; Lee et al., 2010). Here, ERN1 is linked to Alzheimer disease.